Bright Mind Shares Surge 91% After Reporting Positive EEG Clinical Results Of Next-Gen Compound - Bright Minds Biosciences (NASDAQ:DRUG)
After Bright Minds Bioscience's (NASDAQ: DRUG) announcement that its quantitative EEG garnered positive results, the company stock shot up 91% Tuesday morning, spiking to $6.18 from Monday's close of $3.23 per share.
Source: benzinga.com